Mirtazapine Withdrawal: Rebound Insomnia, Nausea, and How to Taper
Clinically reviewed by Elizabeth Lokenauth, PA-C, CAQ-Psy
Reviewed November 5, 2026 · Last updated November 5, 2026
Key Takeaways
- Stopping mirtazapine, especially abruptly, can cause dizziness, abnormal dreams, anxiety, nausea, vomiting, and sweating. The Remeron label recommends lowering the dose gradually.
- Mirtazapine strongly blocks histamine H1 receptors, which drives its sleepiness, and 5-HT3 receptors, a target of anti-nausea drugs. That fits with sleep and stomach symptoms after stopping, though the link hasn't been tested directly.
- Mirtazapine-specific research is thin. One case report describes withdrawal after stopping just 15 mg a day, while trials of the related compound esmirtazapine found no rebound insomnia after an abrupt switch to placebo.
- No antidepressant taper schedule has been validated. A careful plan uses proportional cuts, holds each step until sleep and nausea settle, and returns to the last comfortable dose if symptoms become hard to manage.
You started mirtazapine for depression, or mostly to sleep, and it helped. Now you want off, maybe because of morning grogginess or weight gain, or because you never planned to take it forever. Then you miss a night or two, lie awake at 3 a.m. feeling queasy, and wonder whether this is withdrawal or your old problems coming back. Both are possible, and each calls for a different response.
Every night, mirtazapine blocks several receptors at once. The Remeron prescribing information links its prominent sleepiness to blocking histamine H1 receptors, and it also blocks several serotonin and adrenaline-related receptors. Your brain adapts to a medication it gets every day, and a 2022 review links withdrawal symptoms partly to that adaptation. Coming off smoothly takes precision about pace.
The standard advice is simple. The label lists dizziness, abnormal dreams, anxiety, agitation, nausea, vomiting, and sweating among reactions after stopping, particularly abruptly, and recommends a gradual reduction. Alliance for Sleep guidance says the same for antidepressants used off-label for insomnia. That advice is well founded, and it’s the right place to start.
But neither source says how fast to go, how small the last step should be, or what a bad night means, and at Siggy we think a taper should be paced by how you’re sleeping and feeling rather than by a fixed calendar.
A symptom-guided taper lowers the dose in proportional steps and holds each step until sleep and stomach settle. It treats the final milligrams with the most care, since that’s where mirtazapine’s effect on sleep may change the most. Reading each rough night correctly is a question of pharmacology.
What This Page Covers
- The Short Answer
- What Does Mirtazapine Withdrawal Feel Like?
- Why Sleep and Nausea Can Flare
- Rebound Insomnia or Your Original Insomnia?
- Withdrawal or Relapse? How to Tell
- How Long Does Mirtazapine Withdrawal Last?
- How to Plan a Mirtazapine Taper
- How to Protect Your Sleep and Stomach
- When to Get Help Right Away
- How Siggy Fits In
- Start Your Anonymous Intake
The Short Answer
Yes, mirtazapine withdrawal can happen, particularly after an abrupt stop, and the label recommends lowering the dose gradually. Sleep problems and nausea fit with how the drug works, though mirtazapine-specific research is thin. A slow taper planned with your prescriber, pausing at each step, is the most careful approach.
What Does Mirtazapine Withdrawal Feel Like?
The label lists these reactions after stopping, particularly abruptly:
- Dizziness, tremor, and headache
- Abnormal dreams
- Tingling and electric shock sensations, often called brain zaps
- Anxiety, agitation, and confusion
- Fatigue, nausea, vomiting, and sweating
How often this happens with mirtazapine is unclear. A 2019 withdrawal review found that mirtazapine studies are lacking, though a handful of case reports suggest stopping it can cause withdrawal symptoms.
In one case report, a 69-year-old woman receiving cancer care developed anxiety, restlessness, nausea, insomnia, imbalance, and sensory disturbances after stopping just 15 mg a day. Her symptoms resolved when mirtazapine was restarted. The earlier reports it cites involved young adults stopping 60 mg, so a low dose doesn’t guarantee an easy stop.
Why Sleep and Nausea Can Flare
In a PET study of five healthy men, a single 15 mg dose occupied 80% to 90% of histamine H1 receptors in the brain’s outer layer, and higher occupancy tracked with more sleepiness. When you stop, that blockade lifts as the drug clears, and your sleep system has to run without it. The label notes it’s unclear whether people develop tolerance to mirtazapine’s sleepiness.
Mirtazapine also blocks 5-HT3 receptors, the receptor type targeted by several anti-nausea drugs. In a surgical trial of 100 patients, a single 30 mg dose lowered nausea and vomiting after surgery from 56.3% with placebo to 26.5%. Losing that effect could contribute to withdrawal nausea.
Researchers haven’t tested either link directly, so treat them as reasonable explanations rather than proven ones.
Rebound Insomnia or Your Original Insomnia?
The Alliance for Sleep guideline defines rebound insomnia as insomnia worse than your pre-treatment baseline after a sleep medication stops. It notes that mirtazapine hasn’t been evaluated for discontinuation effects in people with insomnia.
The closest evidence comes from esmirtazapine, one of the two mirror-image forms that make up mirtazapine. In trials summarized by the guideline, people with insomnia who were switched abruptly to placebo, including after 6 months of nightly use, showed no rebound insomnia or withdrawal symptoms. Esmirtazapine remains investigational, so this is reassuring but indirect.
The guideline also expects original insomnia to return in many cases after a sleep medication stops. Rebound tends to fade, while the insomnia you started with tends to stay. A sleep diary helps you tell them apart: each morning, note bedtime, wake time, rough hours slept, and any new symptoms, starting before your first cut. If you took mirtazapine mainly for sleep, an off-label use, our guide to mirtazapine for sleep explains what the trials show.
Withdrawal or Relapse? How to Tell
A 2007 review identified three shared features of antidepressant withdrawal: it starts abruptly within days of stopping, it’s short-lived, and it eases quickly when the medication is restarted. The 2022 review adds that new symptoms point toward withdrawal, while original symptoms at their old intensity point toward relapse.
This comparison draws on both reviews, and any change to your dose should go through your prescriber:
| Pattern | What It Looks Like | Usual Next Step |
|---|---|---|
| Withdrawal | New symptoms, like dizziness or nausea, within days of a cut | Slow down or return to the last dose |
| Rebound | Original symptoms, worse than before, soon after a cut | Hold the dose and check in with your prescriber |
| Relapse | Original symptoms at their old intensity, persisting | Review treatment with your prescriber |
Relapse risk is real if you took mirtazapine for depression. In a 40-trial meta-analysis of 8,890 people, about 21% of those who stayed on the antidepressant that got them well relapsed, compared with about 40% of those switched to placebo. The authors recommend maintenance treatment and careful monitoring for at least 6 months after remission, and the label reports lower relapse over 40 weeks in people who kept taking mirtazapine.
How Long Does Mirtazapine Withdrawal Last?
There’s no mirtazapine-specific answer. Across antidepressants, the 2019 withdrawal review found the likeliest course is onset in the first week after stopping and resolution in the second, while the 2022 review cautions that some people have symptoms for months.
The label puts mirtazapine’s half-life at about 20 to 40 hours, longer on average in women (37 hours) than in men (26 hours). Clearance is also lower in older adults, so the drug may leave some people’s systems more slowly.
How to Plan a Mirtazapine Taper
No trial has defined the best mirtazapine taper, and the 2022 review notes that no antidepressant tapering schedule has been validated. Expect your prescriber to ask how long you’ve taken it, at what dose, and whether you’ve felt off after missed doses, since longer treatment, higher doses, and symptoms after missed doses all raise the risk. Why you took it matters too, because stopping a sleep aid and stopping a depression treatment carry different risks.
Then apply these principles:
- Go slow. The 2022 review’s maxim is “slower is better,” with dose changes every 1 to 4 weeks that may take months to complete. The 2019 withdrawal review recommends tapering over more than four weeks.
- Cut by fractions. A tapering review argued from SSRI imaging data that cuts should shrink as the dose gets lower, ending well below the usual minimum dose. It’s a guide built on SSRIs rather than a mirtazapine rule.
- Respect the last step. Because a single 15 mg dose occupied most H1 receptors in that small PET study, going from a low dose to zero may be the biggest change your sleep system feels. That’s an inference, but it’s a reasonable case for a smaller final step.
- Use the right formulation. Remeron’s 15 mg and 30 mg tablets are scored, while the label says the orally disintegrating SolTab shouldn’t be split. The 2022 review notes that liquids and compounding pharmacies can allow smaller, more precise doses.
- Keep a fallback. If a step brings symptoms you can’t manage, your prescriber may have you return to the previous dose, which usually brings relief within about 24 hours, according to both clinical reviews. The taper can then continue more slowly.
As an illustration rather than a plan to follow on your own, someone on 15 mg might halve the scored tablet to 7.5 mg, hold for 2 to 4 weeks while tracking sleep, and then decide with their prescriber whether to stop or add a smaller final step. Our mirtazapine dosage guide covers the full dosing range.
How to Protect Your Sleep and Stomach
- Ask about CBT-I. AASM insomnia guidance strongly recommends multicomponent cognitive behavioral therapy for insomnia for adults with chronic insomnia, and the Alliance for Sleep guideline notes its benefits tend to last after treatment ends.
- Plan for nausea. Ask your prescriber in advance. The 2022 review lists short-term symptom treatment, such as an anti-nausea medication, as an option alongside slowing down.
- Time your cuts. Avoid stepping down right before travel or a big deadline.
- Skip alcohol and sedatives. The label warns they add to mirtazapine’s impairment, which still applies while you’re tapering.
Our guide to trazodone withdrawal covers a similar step-down for another antidepressant often used for sleep.
When to Get Help Right Away
Most withdrawal symptoms aren’t emergencies, but some need prompt care:
- If you have thoughts of suicide, call or text 988.
- If you faint, have a seizure, or feel you’re in immediate danger, call 911.
- Call your prescriber promptly about new or worsening depression, panic, severe agitation, or an unusual surge of energy with little need for sleep. The 2022 review notes that stopping antidepressants can occasionally trigger mania, and the label calls for close monitoring whenever a dose changes.
How Siggy Fits In
“When side effects start, you’re on your own until the next appointment.” A taper is exactly that stretch, with the hardest nights often falling between visits.
Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions. If you’re weighing coming off mirtazapine, or can’t tell whether you’re feeling withdrawal or your depression returning, the free, anonymous intake takes no name, email, or login. It asks about your medications and symptoms, including sleep. The intake doesn’t diagnose you on its own. A licensed prescriber reviews it before anything is prescribed, and you get a downloadable summary to share with whoever manages your care.
Siggy isn’t an emergency service. If you’re having thoughts of harming yourself, call 911 or call or text 988. This article is for education and isn’t a substitute for your own prescriber’s advice, so don’t stop or change a medication without talking with them first. It reflects sources available as of November 2026.
Start Your Anonymous Intake
Coming off mirtazapine works best as a planned, gradual process with proportional steps, a pause at each one, and a fallback if symptoms flare. A slower taper costs you time, while a rushed one can cost you sleep and make withdrawal harder to tell apart from relapse. The same principles apply to SSRIs, as our guide on how to taper off Lexapro shows. If you want help planning what comes next, start your anonymous intake with Siggy. It’s free, there’s no name or email required, and a licensed prescriber reviews your full picture before anything is prescribed.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
How long does mirtazapine withdrawal last?
It varies, and mirtazapine-specific data are limited. Across antidepressants, a 2019 review found symptoms most often start in the first week after stopping and resolve in the second, though some people have them longer. Contact your prescriber if symptoms persist or feel severe.
Can stopping mirtazapine cause insomnia?
It can. Sleep disturbances are common antidepressant withdrawal symptoms, and the Remeron label lists abnormal dreams among reactions after stopping. Bad nights soon after a cut may be temporary rebound insomnia. If sleep settles back to your pre-treatment pattern and stays there, your original insomnia has returned and needs its own plan, such as CBT-I.
Why does stopping mirtazapine cause nausea?
The Remeron label lists nausea and vomiting among possible reactions after stopping. Mirtazapine blocks 5-HT3 receptors, the target of several anti-nausea drugs, and it reduced nausea and vomiting in a surgical trial. Losing that effect may contribute, but researchers haven't tested the link directly.
Do I need to taper 7.5 mg or 15 mg of mirtazapine?
Talk with your prescriber before stopping at any dose. The label recommends gradual reduction whenever possible, and a published case described anxiety, nausea, insomnia, and imbalance after a woman stopped 15 mg a day, which resolved when she restarted it.
How can I tell withdrawal from depression coming back?
Withdrawal usually starts within days of a dose change, often brings new physical symptoms like dizziness or nausea, and eases quickly if the previous dose is restarted. Relapse looks like your original symptoms returning at their old intensity. Your prescriber can help you sort out which one you're dealing with.
Is mirtazapine withdrawal dangerous?
Most antidepressant withdrawal symptoms are mild and short-lived, and a 2022 clinical review describes them as neither life-threatening nor a sign of addiction. Stopping can occasionally bring suicidal thoughts or, rarely, mania. If you have thoughts of suicide, call or text 988, and call 911 if you're in immediate danger.
Sources
- DailyMed, U.S. National Library of Medicine. Remeron and RemeronSolTab (mirtazapine) Prescribing Information.
- Zwiebel SJ, Viguera AC. Discontinuing antidepressants: pearls and pitfalls. Cleveland Clinic Journal of Medicine. 2022;89(1):18-26.
- Watson NF, Benca RM, Krystal AD, McCall WV, Neubauer DN. Alliance for Sleep clinical practice guideline on switching or deprescribing hypnotic medications for insomnia. Journal of Clinical Medicine. 2023;12(7):2493.
- Henssler J, Heinz A, Brandt L, Bschor T. Antidepressant withdrawal and rebound phenomena. Deutsches Ärzteblatt International. 2019;116(20):355-361.
- Ikenouchi A, Yoshimura R, Nakamura J. A case of discontinuation syndrome following the discontinuation of low-dose mirtazapine therapy in malignant lymphoma. Clinical Neuropsychopharmacology and Therapeutics. 2011;2:30-31.
- Sato H, Ito C, Tashiro M, et al. Histamine H1 receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers. Psychopharmacology. 2013;230(2):227-234.
- Chang FL, Ho ST, Sheen MJ. Efficacy of mirtazapine in preventing intrathecal morphine-induced nausea and vomiting after orthopaedic surgery. Anaesthesia. 2010;65(12):1206-1211.
- Haddad PM, Anderson IM. Recognising and managing antidepressant discontinuation symptoms. Advances in Psychiatric Treatment. 2007;13(6):447-457.
- Kato M, Hori H, Inoue T, et al. Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis. Molecular Psychiatry. 2021;26(1):118-133.
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538-546.
- Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255-262.